MDxHealth SA - Ordinary shares, no par value (MDXH)
CUSIP: B5950S113
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Ordinary shares, no par value
- Shares outstanding
- 53,676,425
- Total 13F shares
- 21,234,231
- Share change
- -1,256,182
- Total reported value
- $30,058,598
- Price per share
- $1.42
- Number of holders
- 21
- Value change
- -$2,917,190
- Number of buys
- 5
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP B5950S113?
CUSIP B5950S113 identifies MDXH - MDxHealth SA - Ordinary shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP B5950S113:
Top shareholders of MDXH - MDxHealth SA - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MVM Partners LLP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
26,337,924
|
$105,351,696 | — | 04 Nov 2021 | |
| Bleichroeder LP |
13D/G
13F
|
Company |
15%
|
7,429,609
|
$24,220,525 | $0 | 19 Mar 2025 | |
| AWM Investment Company, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
4,721,290
|
$11,189,457 | — | 31 Dec 2024 | |
| MVM Partners, LLC |
13F
|
Company |
8.8%
|
4,700,457
|
$11,046,074 | — | 31 Dec 2024 | |
| Samjo Management, LLC |
13F
|
Company |
3.4%
|
1,824,312
|
$4,323,620 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.9%
|
1,007,000
|
$2,386,590 | — | 31 Dec 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
1.8%
|
983,475
|
$2,330,835 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.6%
|
851,688
|
$2,018,501 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
436,062
|
$1,033,467 | — | 31 Dec 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.39%
|
208,000
|
$492,960 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
123,100
|
$291,747 | — | 31 Dec 2024 | |
| Northern Right Capital Management, L.P. |
13F
|
Company |
0.19%
|
103,769
|
$245,933 | — | 31 Dec 2024 | |
| Delta Investment Management, LLC |
13F
|
Company |
0.06%
|
34,000
|
$80,580 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
29,606
|
$70,166 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
26,565
|
$62,959 | — | 31 Dec 2024 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.05%
|
24,425
|
$57,888 | — | 31 Dec 2024 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.04%
|
20,000
|
$47,400 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
10,394
|
$24,633 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,133
|
$12,165 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,498
|
$3,550 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
755
|
$1,789 | — | 31 Dec 2024 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0%
|
250
|
$593 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
200
|
$474 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
72
|
$170 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
29
|
$69 | — | 31 Dec 2024 |
Institutional Holders of MDxHealth SA - Ordinary shares, no par value (MDXH) as of Q1 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.